Komori
Science Arts (4412) · RiskDropped

Impact of COVID-19 Spread on Sales Activities and Business Performance

First written in FY2021. 6 of 10 entries say "Restated". Latest entry: FY2024.

10entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2022-Q2 – FY2022-Q3RestatedFY2022 – FY20242021: 12022: 420222023: 320232024: 22024
Same theme, other companies
Stagnation of Sales Activities and Business Negotiations Due to COVID-19A theme 55 companies write about · 55 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2020: 23 of 48 companies on the "Worse" side.

18 other companies' latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 55 companies compared. The sentences above are computed from all 55.
Full recordFilings, disclosures and news, newest first
  1. FY2024DroppedAnnual report

    「During the fiscal year, Japan's economy followed a gradual recovery trend as the movement of people recovered, personal consumption picked up amid improving employment and income conditions, and inbound demand increased following the reclassification of COVID-19 as a Category V disease under the Infectious Diseases Control Law.」

    Restrictions on sales activities and the impact on business performance resulting from COVID-19 were no longer described as a standalone business risk, while economic normalization following the Category V reclassification was noted.
  2. FY2024-Q1RestatedAnnual report

    「During the cumulative first-quarter period, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company stated that there were no material changes to business and other risks. It also explained that economic and social activity had been progressing toward normalization following the reclassification of COVID-19 as a Category V disease.
  3. FY2023-Q3RestatedAnnual report

    「During the nine-month period ended 31 December, Japan's economy began to show signs of a gradual recovery in economic activity, including the effects of various policies addressing COVID-19 and increased personal consumption following the easing of restrictions on activities. However, the outlook for the economy remained uncertain due to fluctuations in foreign exchange markets caused by the rapid depreciation of the yen and surging global resource and fuel prices resulting from the situation involving Russia and Ukraine.」

    The company referred to the effects of policies addressing COVID-19 and the easing of restrictions on activities, while stating that there were no material changes to business and other risks.
  4. FY2023-Q2RestatedAnnual report

    「During the six-month period ended 30 September, Japan's economy began to show signs of a gradual recovery in economic activity, including the effects of various policies addressing COVID-19 and increased personal consumption following the easing of restrictions on activities. However, the outlook for the economy remained uncertain due to fluctuations in foreign exchange markets caused by the rapid depreciation of the yen and surging global resource and fuel prices resulting from the situation involving Russia and Ukraine.」

    The company referred to the effects of policies addressing COVID-19 and the easing of restrictions on activities, while stating that there were no material changes to business and other risks.
  5. FY2023-Q1RestatedAnnual report

    「There were no new business risks or material changes to the business risks described in the annual securities report for the previous fiscal year during the three-month period ended 30 June. The company will continue to monitor the impact of the COVID-19 pandemic on its business.」

    The company stated that there were no new risks or material changes, while continuing to monitor the impact of COVID-19 on its business.
  6. FY2022RestatedAnnual report

    「With respect to COVID-19, we have implemented infection-control measures, including thorough hygiene management and recommending working from home. During the state of emergency from April 2020, it was demonstrated that most operations could be handled remotely. However, sales activities were affected because face-to-face sales activities by clients and distributors were restricted.」

    While the company described business continuity measures through working from home, it continued to note the possibility of an ongoing impact on face-to-face sales activities.
  7. FY2022-Q3MaterialisedAnnual report

    「In the Buddycom business, sales activities were restricted due to the spread of COVID-19, and there were cancellations of short-term contracts for the Olympic and Paralympic Games, among other impacts. However, the number of contracted companies increased due to greater brand awareness from strengthened marketing and stronger sales capabilities among distributors. As of the end of the third quarter, the number of contracted companies was 538 (400 at the end of the previous fiscal year). In addition, partly due to winning large contracts in amusement, railways and other sectors, ARR※ was ¥374.788 million (¥295.703 million at the end of the previous fiscal year, including ¥17.970 million from short-term contracts during the Olympic and Paralympic Games).」

    While restrictions on sales activities and cancellations of short-term contracts continued to occur during the cumulative period, the number of contracted companies and ARR increased.
  8. FY2022-Q2MaterialisedAnnual report

    「In the Buddycom business, sales activities were restricted and short-term contracts for use during the Olympic and Paralympic Games were cancelled due to the COVID-19 pandemic. However, the number of contracted companies increased as a result of greater awareness through strengthened marketing and stronger sales capabilities among distributors. At the end of the six-month accounting period, the number of contracted companies was 479, compared with 400 at the end of the previous fiscal year, and ARR※ was ¥308.119 million, compared with ¥295.703 million at the end of the previous fiscal year, including ¥17.970 million from short-term contracts for use during the Olympic and Paralympic Games.」

    While restrictions on sales activities and cancellations of short-term contracts continued to occur, the number of contracted companies and ARR increased.
  9. FY2022-Q1RestatedAnnual report

    「There were no new business risks or material changes to the business risks described in the annual securities report for the previous fiscal year during the three-month period ended 30 June. The company will continue to monitor the impact of the COVID-19 pandemic on its business.」

    The company stated that there were no new risks or material changes, while noting that it would continue to monitor the impact of COVID-19 on its business.
  10. FY2021First statedAnnual report

    「In the Buddycom business, the COVID-19 pandemic restricted sales activities and resulted in cancellations by existing customers, particularly in industries such as transportation that were heavily affected.」

    While restrictions on sales activities and cancellations by existing customers actually occurred, the company also described proposals for telework-related services as a growth opportunity.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Science Arts's next results are scheduled for 2026-10-15. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact of COVID-19 Spread on Sales Activities and Business Performance | Science Arts,Inc. (4412) | Komori